Skip to main content
See every side of every news story
Published • loading... • Updated

Pancreatic Cancer Was Controlled In 90% Of Patients In Trial

Summary by Mindbodygreen
An early trial found daraxonrasib plus chemo controlled metastatic pancreatic cancer in 90.2% of patients. Here's what the results mean, and don't yet.

4 Articles

Progress in the treatment of pancreatic cancer: Daraxonrasib has kept the disease under control in 90% of patients in a study A treatment combining a daily pill called daraxonrasib with chemotherapy has achieved promising results in patients with advanced pancreatic cancer. In a clinical study conducted in 61 people, the disease has been kept under control in 90.2% of participants, and more than 60% of tumors have significantly decreased or beco…

sensational news: a new treatment against pancreatic cancer managed to make the tumors disappear from the examinations of five patients and reduce their size in dozens of others. The results, released this week, show that the combination of a daily tablet with chemotherapy managed to control the disease in 90.2% of the participants in a clinical study. [...]

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

mindbodygreen broke the news on Saturday, November 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal